Similar articles for PMID: 21115930

Year	Number of Results
1990	1
1997	1
1998	2
1999	2
2000	5
2001	2
2002	2
2003	3
2004	3
2005	9
2006	7
2007	6
2009	7
2010	6
2011	7
2012	6
2013	8
2014	5
2015	4
2017	2
2018	1
2020	1
2021	1

1

Immunohistochemical staining with deltaNp63 is useful for distinguishing the squamous cell component of adenosquamous cell carcinoma of the lung.

Uramoto H, Yamada S, Hanagiri T. Uramoto H, et al. Anticancer Res. 2010 Nov;30(11):4717-20. Anticancer Res. 2010. PMID: 21115930

2

A lack of prognostic significance regarding DeltaNp63 immunoreactivity in lung cancer.

Iwata T, Uramoto H, Sugio K, Fujino Y, Oyama T, Nakata S, Ono K, Morita M, Yasumoto K. Iwata T, et al. Lung Cancer. 2005 Oct;50(1):67-73. doi: 10.1016/j.lungcan.2005.03.039. Lung Cancer. 2005. PMID: 15950316

3

The use of p63 as an effective immunomarker in the diagnosis of pulmonary squamous cell carcinomas on de-stained bronchial lavage cytological smears.

Uke M, Rekhi B, Ajit D, Jambhekar NA. Uke M, et al. Cytopathology. 2010 Feb;21(1):56-63. doi: 10.1111/j.1365-2303.2009.00678.x. Epub 2009 Sep 9. Cytopathology. 2010. PMID: 19744186

4

p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?

Pelosi G, Pasini F, Olsen Stenholm C, Pastorino U, Maisonneuve P, Sonzogni A, Maffini F, Pruneri G, Fraggetta F, Cavallon A, Roz E, Iannucci A, Bresaola E, Viale G. Pelosi G, et al. J Pathol. 2002 Sep;198(1):100-9. doi: 10.1002/path.1166. J Pathol. 2002. PMID: 12210069

5

The prognostic impact of sex on surgically resected non-small cell lung cancer depends on clinicopathologic characteristics.

Sterlacci W, Tzankov A, Veits L, Oberaigner W, Schmid T, Hilbe W, Fiegl M. Sterlacci W, et al. Am J Clin Pathol. 2011 Apr;135(4):611-8. doi: 10.1309/AJCPQF24NYWNMVMG. Am J Clin Pathol. 2011. PMID: 21411784

6

p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.

Lo Muzio L, Santarelli A, Caltabiano R, Rubini C, Pieramici T, Trevisiol L, Carinci F, Leonardi R, De Lillo A, Lanzafame S, Bufo P, Piattelli A. Lo Muzio L, et al. Hum Pathol. 2005 Feb;36(2):187-94. doi: 10.1016/j.humpath.2004.12.003. Hum Pathol. 2005. PMID: 15754296

7

Expression of the p53 family in lung cancer.

Uramoto H, Sugio K, Oyama T, Nakata S, Ono K, Nozoe T, Yasumoto K. Uramoto H, et al. Anticancer Res. 2006 May-Jun;26(3A):1785-90. Anticancer Res. 2006. PMID: 16827107 Free article.

8

A study of ΔNp63 expression in lung non-small cell carcinomas.

Nonaka D. Nonaka D. Am J Surg Pathol. 2012 Jun;36(6):895-9. doi: 10.1097/PAS.0b013e3182498f2b. Am J Surg Pathol. 2012. PMID: 22367298

9

Expression of p63, keratin 5/6, keratin 7, and surfactant-A in non-small cell lung carcinomas.

Camilo R, Capelozzi VL, Siqueira SA, Del Carlo Bernardi F. Camilo R, et al. Hum Pathol. 2006 May;37(5):542-6. doi: 10.1016/j.humpath.2005.12.019. Hum Pathol. 2006. PMID: 16647951

10

Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.

Castro CY, Stephenson M, Gondo MM, Medeiros LJ, Cagle PT. Castro CY, et al. Mod Pathol. 2000 Jul;13(7):808-13. doi: 10.1038/modpathol.3880141. Mod Pathol. 2000. PMID: 10912942

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed